CSPIA
VXRT

Cary Street Partners Investment Advisory’s Vaxart VXRT Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,000
Closed -$754 – 1767
2023
Q3 		$754 Hold
1,000
– – ﹤0.01% 1760
2023
Q2 		$730 Hold
1,000
– – ﹤0.01% 1671
2023
Q1 		$757 Hold
1,000
– – ﹤0.01% 1590
2022
Q4 		$961 Buy
+1,000
New +$1.41K ﹤0.01% 1586

Other funds holding VXRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Cary Street Partners Investment Advisory's VXRT Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Vaxart (VXRT) in Q4 2023, closing a stake of 1,000 shares — an estimated $754 sold.

Cary Street Partners Investment Advisory first reported a position in VXRT in Q4 2022 and held it in 4 quarters. The position peaked at $961 in Q4 2022. 87 funds tracked by Wall St. Rank hold VXRT as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Vaxart position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 1,000 Vaxart shares in Q4 2023, an estimated $754.
  • Cary Street Partners Investment Advisory first reported a position in Vaxart in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Vaxart position peaked at $961 in Q4 2022.
  • 87 funds tracked by Wall St. Rank held Vaxart as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.